Browsing: Clinical

48-2 Kawasaki or MIS-C.png
COVID-19 , Pediatric EM , Cardiology

Kawasaki Disease or MIS-C?

4/8/2021 Blair Gaines, MD
Clinical knowledge regarding how the COVID-19 virus affects children is still evolving. Multisystem Inflammatory Syndrome in Children (MIS-C) can be approached in the same way as a Kawasaki-Like Hyper
hpjc-0421.jpg
Health Policy Journal Club , Health Policy , Advocacy , Health Care Administration , Informatics

Health Policy Journal Club: Sacrificing Efficiency for Safety

4/6/2021 Florian Schmitzberger, MD, MS , Cedric Dark, MD, MPH, FACEP
Does limiting the number of open charts in an electronic medical record reduce medical error? Survey says... no.
cca-crystalloids.jpg
Critical Care , Critical Care Alert , Sepsis

Critical Care Alert: Effect of Early Balanced Crystalloids Before ICU Admission on Sepsis Outcomes

4/5/2021 Jonathan Pickos, DO , Brian Sumner, MD
When and what type of IV fluid should you administer for critically ill patients in order to achieve the best outcome in terms of sepsis? This study examines balanced fluid resuscitation started in th
cca-nac.jpg
Critical Care , Critical Care Alert

Critical Care Alert: Role of N-Acetylcysteine in Non-acetaminophen-related Acute Liver Failure

4/5/2021 Jonathan Pickos, DO , Brian Sumner, MD
Non-acetaminophen-related causes of acute liver failure are inevitably going to present in the emergency department, and acknowledging that NAC likely has a place in the care of these patients is impo
CCA-HOT ICU.jpg
Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure (The HOT-ICU Trial)

3/22/2021 Nicholas Huth , Jonathan Pickos, DO , Brian Sumner, MD
The ideal oxygenation goal in patients with acute respiratory failure in the ICU remains unclear. The HOT ICU trial seeks to provide insight.
CCA-Receptor Antagonists.jpg
Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Interleukin-6 Antagonists in Critically Ill Patients with COVID-19

3/18/2021 Oswald Reid, Jr., MD , Brian Sumner, MD
While much is still left to be known about COVID-19, research has supported the theory that an excessive host inflammatory response is responsible for much of the morbidity and mortality seen by the d
CCA-Tocilizumab.jpg
Critical Care , Critical Care Alert , COVID-19

Critical Care Alert: Tocilizumab in Patients Admitted to Hospital with COVID-19 (RECOVERY)

3/18/2021 Taylor Miller, MD , Brian Sumner, MD
Originally designed for use in rheumatoid arthritis, tocilizumab is being considered as a potential therapeutic agent to treat COVID-19.
VICTAS.jpg
Critical Care , Critical Care Alert , Sepsis

Critical Care Alert: Effect of Vitamin C, Thiamine and Hydrocortisone on Ventilator- and Vasopressor-Free Days in patients with sepsis - The VICTAS Randomized Clinical Trial

3/15/2021 Brian Sumner, MD
Does treatment with vitamin C, thiamine, and hydrocortisone lead to an increase in the number of days alive and free of mechanical ventilation and vasopressor use? The latest EMRA Critical Care Alert
hpjc-0321.jpg
Health Policy Journal Club , Health Policy , Advocacy , COVID-19

Health Policy Journal Club: Patient Visits Plummet During Pandemic

3/6/2021 Clinton Lam , Cedric Dark, MD, MPH, FACEP
A recent study investigated COVID-19's impact on hospital visits. Patient volume plummeted - disproportionately affecting populations that already struggle with systemic inequities in healthcare.
CCA-beta blockers.png
Critical Care , Critical Care Alert , Cardiology , Sepsis

Critical Care Alerts: Effect of Ultra-Short-Acting Beta-blockers on Mortality in Patients with Persistent Tachycardia Despite Initial Fluid Resuscitation: A Systematic Review and Meta-Analysis

3/3/2021 Nicholas Huth , Jonathan Pickos, DO , Brian Sumner, MD
The latest EMRA Critical Care Alert examines a study that questions whether ultra-short-acting beta-blockers, such as esmolol and landiolol, reduced 28-day mortality in septic patients with persistent